The Hologic Aptima SARS‐CoV‐2 assay enables high ratio pooling saving reagents and improving turnaround time

BACKGROUND: The Hologic Aptima™ TMA SARS‐CoV‐2 assay was employed to test pooled nasopharyngeal (NP) samples to evaluate the performance of pooled sample testing and characterize variables influencing results. METHODS: Results on 1033 previously tested NP samples were retrieved to characterize the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Newsom, Kimberly, Zhang, Yuan, Chamala, Srikar, Martinez, Katherine, Clare‐Salzler, Michael, Starostik, Petr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418467/
https://www.ncbi.nlm.nih.gov/pubmed/34213803
http://dx.doi.org/10.1002/jcla.23888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418467/
https://www.ncbi.nlm.nih.gov/pubmed/34213803
http://dx.doi.org/10.1002/jcla.23888

Ejemplares similares